BOTH OTC
Bioethics, Ltd.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: -99.6%
3Y: -97.7%
5Y: -99.8%
$0.01
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$123K
-143.5% ▼
Net Income
-$177K
-82.1% ▼
EPS (Diluted)
$-0.12
-40.2% ▼
EBITDA
-$123K
+0.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $286 | $226 | $0 | $0 | $0 |
| Gross Profit | -$286 | -$226 | $0 | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $75K | $59K | $47K | $50K | $123K |
| Operating Expenses | $75K | $59K | $47K | $50K | $123K |
| Operating Income | -$75K | -$59K | -$47K | -$50K | -$123K |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $44K | $48K | $46K | $47K | $54K |
| Income Before Tax | -$119K | -$107K | -$93K | -$97K | -$177K |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$119K | -$107K | -$93K | -$97K | -$177K |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.10 | $-0.09 | $-0.08 | $-0.09 | $-0.12 |
| EBITDA | -$75K | -$59K | -$47K | $0 | -$123K |
| Shares Outstanding | 1M | 1M | 1M | 1M | 1M |